Cellular Dynamics International and Promega Corp. have entered into a research collaboration to develop toxicity tests for drug developers that use stem-cell derived heart cells. The companies, both based in Madison, said the collaboration has potential to provide pharmaceutical company researchers with more predictive data, driving the development of safer and more effective drugs. Cellular Dynamics was founded by stem cell pioneer James Thomson and several other UW-Madison researchers
Office of Strategic Communication